Virtual Tumouor™ is Physiomics’ proprietary software platform used to simulate the effects of anti-cancer agents on pre-clinical and human tumours. It is used by companies ranging from start up biotech to global large cap pharmaceuticals.
Physiomics provides a full range of PK/PD services, usually in support of smaller companies where this function is outsourced. Our staff are experienced in creating both pharmacokinetic and pharmacodynamic models to represent a variety of cancers at all stages of development.
Complex “pathway” models are still common in literature and are also used by some companies, for example, to generate and test hypotheses relating to more detailed molecular interactions. Physiomics’ has significant experience in both creating such models or recreating them from literature.